Clinical Trial Update: Experimental Malaria Infection of Healthy Malaria-Naive Adults by Mosquito Bite With the Genetically Modified Plasmodium Falciparum NF54/iGP3 GAP [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for experimental malaria infection in healthy malaria-naive adults using genetically modified Plasmodium falciparum NF54/iGP3 GAP;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: University of Melbourne | Conditions: Malaria Falciparum, Malaria Infection | Phase 1 | Status: NOT_YET_RECRUITING